Literature DB >> 11032490

Gabapentin, an adjuvant treatment for neuropathic pain in a cancer hospital.

A Chandler, J E Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11032490     DOI： 10.1016/s0885-3924(00)00166-4

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  4 in total

1.  Neuropathic Pain in Pediatric Oncology: A Clinical Decision Algorithm.

Authors:  Doralina L Anghelescu; Jessica Michala Tesney
Journal:  Paediatr Drugs       Date:  2019-04       Impact factor: 3.022

Review 2.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Intrathecal gabapentin enhances the analgesic effects of subtherapeutic dose morphine in a rat experimental pancreatitis model.

Authors:  Matthew M Smiley; Ying Lu; Louis P Vera-Portocarrero; Amr Zidan; Karin N Westlund
Journal:  Anesthesiology       Date:  2004-09       Impact factor: 7.892

4.  A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain.

Authors:  Hidenori Takahashi; Naohito Shimoyama
Journal:  Int J Clin Oncol       Date:  2010-02       Impact factor: 3.402
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.